Early Postmarket Results with EmboTrap II Stent Retriever for Mechanical Thrombectomy: A Multicenter Experience.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
21
08
2020
accepted:
23
11
2020
pubmed:
13
3
2021
medline:
10
7
2021
entrez:
12
3
2021
Statut:
ppublish
Résumé
EmboTrap II is a novel stent retriever with a dual-layer design and distal mesh designed for acute ischemic stroke emergent large-vessel occlusions. We present the first postmarket prospective multicenter experience with the EmboTrap II stent retriever. A prospective registry of patients treated with EmboTrap II at 7 centers following FDA approval was maintained with baseline patient characteristics, treatment details, and clinical/radiographic follow-up. Seventy patients were treated with EmboTrap II (mean age, 69.9 years; 48.6% women). Intravenous thrombolysis was given in 34.3%, and emergent large-vessel occlusions were located in the ICA ( Initial postmarket results with the EmboTrap II stent retriever are favorable and comparable with those of other commercially available stent retrievers. Compared with EmboTrap II, the first-generation EmboTrap may have a higher first-pass efficacy; however, data are limited by retrospective case analysis, incomplete clinical follow-up, and small sample size, necessitating future trials.
Sections du résumé
BACKGROUND AND PURPOSE
EmboTrap II is a novel stent retriever with a dual-layer design and distal mesh designed for acute ischemic stroke emergent large-vessel occlusions. We present the first postmarket prospective multicenter experience with the EmboTrap II stent retriever.
MATERIALS AND METHODS
A prospective registry of patients treated with EmboTrap II at 7 centers following FDA approval was maintained with baseline patient characteristics, treatment details, and clinical/radiographic follow-up.
RESULTS
Seventy patients were treated with EmboTrap II (mean age, 69.9 years; 48.6% women). Intravenous thrombolysis was given in 34.3%, and emergent large-vessel occlusions were located in the ICA (
CONCLUSIONS
Initial postmarket results with the EmboTrap II stent retriever are favorable and comparable with those of other commercially available stent retrievers. Compared with EmboTrap II, the first-generation EmboTrap may have a higher first-pass efficacy; however, data are limited by retrospective case analysis, incomplete clinical follow-up, and small sample size, necessitating future trials.
Identifiants
pubmed: 33707283
pii: ajnr.A7067
doi: 10.3174/ajnr.A7067
pmc: PMC8115375
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
904-909Informations de copyright
© 2021 by American Journal of Neuroradiology.
Références
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Lancet. 2012 Oct 6;380(9849):1231-40
pubmed: 22932714
Stroke. 2018 May;49(5):1107-1115
pubmed: 29643261
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
J Neurointerv Surg. 2016 Feb;8(2):197-202
pubmed: 25540180
Interv Neuroradiol. 2019 Jun;25(3):271-276
pubmed: 30714502
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Interv Neurol. 2017 Oct;6(3-4):268-276
pubmed: 29118805
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510